Monday June 26th 2017

Archive for April, 2017

MS Society of Canada Urges Members of Parliament to Act to Improve #LifeWithMS

MS Society of Canada Urges Members of Parliament to Act to Improve #LifeWithMS

Multiple Sclerosis Society of Canada and members of MS community to launch MS Awareness Month in Ottawa with focus on getting government to take action to improve Life With MS (Source: Disabled World) [Read More]

CME Outfitters Demonstrates Successful Integration of the Patient…

CME Outfitters Demonstrates Successful Integration of the Patient…

CMEO webcast activity on multiple sclerosis proves successful in incorporating the patient voice directly into educational content(PRWeb April 29, 2017)Read the full story at http://www.prweb.com/releases/2017/05/prweb14292245.htm (Source: PRWeb: Medical [Read More]

Nose2Brain project aims to develop better therapy for multiple sclerosis

Nose2Brain project aims to develop better therapy for multiple sclerosis

Medically active substances are normally distributed via the blood - either directly by injection into the bloodstream or indirectly, for example through the digestive tract after oral administration. [Read More]

 Page 1 of 24  1  2  3  4  5 » ...  Last » 

Latest Topics

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

Are static and functional balance abilities related in individuals with Multiple Sclerosis? – Pau M, Porta M, Coghe G, Corona F, Pilloni G, Lorefice…

BACKGROUND: In people with Multiple Sclerosis (pwMS), balance assessment is essential in estimating the risk of falls, [Read More]

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis CHMP Recommends Cladribine (Mavenclad) for Multiple Sclerosis

The European Medicines Agency ’ s Committee for Medicinal Products for Human Use recommends approval of cladribine to [Read More]

Germany’s Merck gets EU backing for oral MS drug

Germany’s Merck gets EU backing for oral MS drug

FRANKFURT (Reuters) - Germany's Merck KGaA has won a key recommendation to become a late entrant to the market for oral [Read More]

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

New data at EAN show Roche ’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in relapsing and primary…

Roche announced today that new post-hoc analyses from the OCREVUS ™ (ocrelizumab) Phase III clinical trial programme [Read More]

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

MS Society Hosts Joint Congressional Briefing on the Value of Rehabilitation

/About-the-Society/News/Society-Hosts-Joint-Congressional-Briefing-on-the [Read More]